活性氧
癌症免疫疗法
乳腺癌
免疫疗法
癌症
纳米颗粒
癌症研究
化学
医学
纳米技术
生物化学
材料科学
内科学
作者
Wanting Yang,Ziyao Zhang,Jingxia Xu,Zihe Peng,Fangming Zhang,Xinyu Zhao,Guofeng Li,Yen Wei,Lingyun Zhao,Lin Wang,Xing Wang,Wensheng Xie
标识
DOI:10.1021/acsanm.5c02985
摘要
Advanced breast cancer still suffers a low survival rate and incurable outcome, despite the fact that targeted therapy has significantly improved the therapeutic efficacy. Clinical trials have demonstrated that the combination of immunotherapy and chemotherapy via inducing immunogenicity of tumor cell death during chemotherapy could make a difference. Thus, in this study, both bimetallic FePd nanoparticles (NPs) and 6-diazo-5-oxo-l-norleucine (DON) coloaded reactive oxygen species (ROS)-generating lipid nanoparticles (Lip@FePd-DON NPs) were prepared via the classical thin-film hydration method to enhance necroptotic chemo-immunotherapy for breast cancer treatment. Upon internalization by tumor cells, the Fenton-like performance of bimetallic FePd NPs catalyze intracellular H2O2 into toxic ROS. Then, the combination of DON and ROS could effectively induce cell necroptosis via the RIPK3/MLKL pathway. The immunogenicity of necroptotic cell death releases damage-associated molecular patterns, which act as in situ neoantigens to trigger DC maturation and T cell activation, resulting in an efficient immune response with upregulated expression of inflammatory cytokines (TNF-α, IFN-γ, and IL-6). In vivo antitumor evaluation based on tumor-bearing mice displayed highly efficient tumor growth inhibition via enhancing necroptotic chemo-immunotherapy. Considering the in vivo biocompatibility, this study demonstrated ROS-generating lipid nanoparticles as potential carriers to deliver DON for enhancing necroptotic chemo-immunotherapy of breast cancer, which may promote the development of personalized nanoplatforms for breast cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI